To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Rufinamide is an anticonvulsant medication.
Additional recommended knowledge
Used in combination with other medication and therapy to treat Lennox-Gastaut syndrome and various other seizure disorders, Rufinamide, a triazole derivative, was developed in 2004 by Novartis Pharma, AG, and is manufactured by Eisai.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Rufinamide". A list of authors is available in Wikipedia.|